Brief: Y-mAbs Announces Regulatory Filing For DANYELZA (naxitamab-gqgk) In Brazil
26/09/2022 14:47
Sept 26 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS ANNOUNCES REGULATORY FILING FOR DANYELZA
(NAXITAMAB-GQGK)
IN BRAZIL
Source text for Eikon: ID:nGNX9Vy2tD
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary